Let the Molecule Lead: A More Focused Approach to Formulation Development

Early formulation decisions can shape an entire development program. In this Q&A with Pharmaceutical Outsourcing, AustinPx Chief Scientific Officer Dave Miller, Ph.D., discusses how targeted preformulation, predictive modeling, and parallel screening help teams determine whether a molecule can advance with a conventional formulation or requires bioavailability enhancement. He also explains how evaluating spray drying, hot-melt extrusion, and KinetiSol™ under one roof supports confident, data-driven technology selection while conserving time and material.